9% of 6033 hypogonadal men reporting prior AAS use in a recent retrospective study
Tamoxifen treatment was associated with improved DFS for MBC patients
Tamoxifen is an off-label option to treat men for breast cancer, infertility, and idiopathic gynecomastia
If taken for a 5-year period, the oestrogen-blocking drug tamoxifen significantly reduces breast-cancer recurrence;1 however, the incidence of debilitating hot flushes is substantially increased
Normozoospermic men were followed for the same period
Here, we present the 10-year results
Tamoxifen became the treatment of first choice for virtually all clinical situations but the advent of well-tolerated third-generation aromatase inhibitors and selective oestrogen receptor degraders (SERDs) has resulted in a decline in the use of tamoxifen in most settings
Method: Fifty-seven men receiving tamoxifen for iOAT were recruited from 2016 to 2017 in a retrospective, single-centre setting
Human male sexual functions do not require aromatization of testosterone: a study using tamoxifen, testolactone, and dihydrotestosterone Arch Sex Behav
Lately, tamoxifen has been proposed as a treatment to prevent gynecomastia in prostate cancer patients receiving antiandrogen therapy
[] Symptoms associated with decline in testosterone are often assessed using questionnaires such as the androgen deficiency in the aging male (ADAM) and quantitative ADAM (qADAM)
Sep-Oct 2005;26(5):565-6; author reply 566-7
Its causes range from benign physiological processes to rare neoplasms
Design: A total of 48 normogonadotropic men with idiopathic oligozoospermia were allocated in to six groups (n = 8 per group) treated with placebo, 40 mg T undecanoate three times per day, 10 mg Administration of the antiestrogen tamoxifen for one month to 12 patients with idiopathic oligozoospermia significantly increased the mean basal testosterone (T) level and the responses of luteinizing hormone (LH) and follicle stimulating hormone (FSH) to constant luteinizing hormone releasing hormone (LHRH) infusion but did not significantly influence the mean oestradiol (E2) levels or the E2 Objectives: To compare serum testosterone response and symptom improvement in men with hypogonadism in response to treatment with clomiphene citrate (CC), human chorionic gonadotropin (hCG), or a combination of both therapies
Since a balance exists Doses of 10-40 mg of tamoxifen per day were used in adolescent males under the age of twenty for 1-12 months, with the resolution of mastodynia and ≥80% reduction in swelling noted
In this prospectively enrolled cohort study, 448 patients with MBC were treated between May 2009 and June 2018
T
To investigate the effects of these drugs on gene expression in breast cancer cells, we treated estrogen receptor-positive MCF-7 cells stably transfected with the aromatase gene (known as MCF-7aro cells) with testosterone, 17 beta-estradiol, two aromatase inhibitors (letrozole and anastrozole), and an antiestrogen (tamoxifen)
Relative risks (RRs) and 95% confidence intervals (CIs) for invasive breast cancer were estimated for each quartile of sex hormone level using Cox proportional hazards models
true
), a medicinal plant widely used in traditional medicine, displays multiple biological effects, ranging from beneficial to toxic
FSH or tamoxifen were able to regain spermatogenesis to a concentration of 22 million per mL The dose of tamoxifen was increased in three patients due to poor response
It summarizes the evidence from in vitro, in vivo, and clinical studies on the effects of DIM on estrogen receptors, aromatase inhibitors, and tamoxifen
It is concluded that testosterone inhibits FSH secretion in Total testosterone, bioavailable testosterone, oestradiol and testosterone:oestradiol ratio were measured before combination therapy (treatment with CC only) and at CC + AZ combination therapy follow-ups
Nolvadex (tamoxifen) is a potent antiestrogen Maecenas luctus lectus
The present experiments were conducted to analyse whether the SERMs, tamoxifen and raloxifene, can cause oestrogenic actions during the hypothalamic differentiation period
Tamoxifen treatment was associated with improved DFS for MBC patients
In postmenopausal women, oestradiol, testosterone, sex hormone binding globulin (SHBG) and dehydroepiandrosterone sulphate (DHEA-S) may contribute to the
Lately, tamoxifen has been proposed as a treatment to prevent
Tamoxifen Book In: StatPearls [Internet]